(Q39565625)

English

Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.

scientific article published on November 1988

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

review article

1 reference

stated in

Europe PubMed Central

title

Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

Foote JE

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

Crawford ED

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

language of work or name

1 reference

1 November 1988

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

volume

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

page(s)

291-302

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

Identifiers

PubMed publication ID

3068767

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3068767

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3068767%20AND%20SRC:MED&resulttype=core&format=json

(Q39565625)

Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)